Morosini Deborah

CIK 00018246251 companyWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001824625

Recent Transactions

22 trades

Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2022-02-15+90,000→ 90,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-12-15−24,853→ 74,575 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-12-15−882→ 195,163 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-12-15$12.85/sh+25,735→ 29,195 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-12-15$13.00/sh−28,751→ 444 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-12-15−3,016→ 1,307 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-12-15$1.89/sh+3,016→ 3,460 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-11-16$12.85/sh+28,751→ 29,195 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-11-16$15.87/sh−28,351→ 844 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-11-16$16.43/sh−400→ 444 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-11-16−28,751→ 196,045 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-07-20+85,000→ 85,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-29$40.29/sh−3,223→ 444 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-29$1.89/sh+3,223→ 3,667 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-04-29−3,223→ 4,323 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-08$40.00/sh−100→ 444 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-04-08−100→ 7,546 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-08$1.89/sh+100→ 544 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-07$1.89/sh+1,000→ 1,444 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-07$40.04/sh−1,000→ 444 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-04-07−1,000→ 7,646 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2020-09-29$19.00/sh+444→ 444 total

Companies

Prelude Therapeutics Inc
EVP, Chief of Clinical Affairs
$PRLD

Recent Filings

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 200 POWDER MILL ROAD

WILMINGTON, DE, 19801

View on SEC.gov